Latest Pneumococcal conjugate vaccine Stories
Scientists recently revealed that they plan to study the pneumococcal vaccines in older adults to determine if there’s a strong immune response due to a higher dosage of the vaccine.
The vaccine given to children to immunize against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.
Genetics has provided surprising insights into why vaccines used in both the UK and US to combat serious childhood infections can eventually fail.
Grant MacKenzie of the MRC Unit in The Gambia and colleagues describe in this week's PLoS Medicine how they set up a population-based surveillance system to assess the impact of pneumococcal conjugate vaccines (PCVs) on invasive pneumococcal disease (IPD) and radiological pneumonia in children in The Gambia.
- Growing in low tufty patches.